<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药事纵横 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-10T01:19:38+08:00</updated>
  <subtitle>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！投稿请发442015666@qq.com</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>低剂量口服固体制剂开发——工艺路线的选择</title>
    <updated>2020-11-09T21:01:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/ELQpe31bOwHlbSRoDT-oAQ</id>
    <link href="https://mp.weixin.qq.com/s/ELQpe31bOwHlbSRoDT-oAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【倒计时10天】2020药品上市许可持有人（MAH）政策解读与生产许可证申请实施培训</title>
    <updated>2020-11-09T21:01:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/OgmktUbTKvgyBOdibqOfTA</id>
    <link href="https://mp.weixin.qq.com/s/OgmktUbTKvgyBOdibqOfTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>液液相分离，未来的</title>
    <updated>2020-11-09T21:01:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/98gHQQJ2LWws8B6Jo0VoVA</id>
    <link href="https://mp.weixin.qq.com/s/98gHQQJ2LWws8B6Jo0VoVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BCS分类中 的“剂量”是最大市售剂量还是单次最大给药剂量？</title>
    <updated>2020-11-09T21:01:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/qOb5EoHoiY4vhyI4G3URCA</id>
    <link href="https://mp.weixin.qq.com/s/qOb5EoHoiY4vhyI4G3URCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浅谈药品质量体系建立和运行</title>
    <updated>2020-11-09T09:59:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/ID1hr4r8pN0AvtVPaNDo_w</id>
    <link href="https://mp.weixin.qq.com/s/ID1hr4r8pN0AvtVPaNDo_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有人@你，药物制剂前沿技术高峰论坛来了</title>
    <updated>2020-11-09T09:59:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/FnLFXQ0LUSCink7eKp1_jg</id>
    <link href="https://mp.weixin.qq.com/s/FnLFXQ0LUSCink7eKp1_jg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药学速览万字长书解读| 多肽牵手纳米，助力肿瘤治疗</title>
    <updated>2020-11-09T09:59:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/9JIpUCTfJ1XhPk88pO8wzw</id>
    <link href="https://mp.weixin.qq.com/s/9JIpUCTfJ1XhPk88pO8wzw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>100篇文章助你成为I期临床/BE/溶出试验方面的专家</title>
    <updated>2020-11-09T09:59:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/yUMI7PEL-sGawXUHNkUF0w</id>
    <link href="https://mp.weixin.qq.com/s/yUMI7PEL-sGawXUHNkUF0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>质量研究中遇到的几个常见问题的思考</title>
    <updated>2020-11-05T20:33:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/9AgwP9uysfaSE_7yyxlUSw</id>
    <link href="https://mp.weixin.qq.com/s/9AgwP9uysfaSE_7yyxlUSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百亿PPI市场，集采后会怎样？</title>
    <updated>2020-11-05T20:33:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/v2sRMQY7F7lGtNjU0RWAMg</id>
    <link href="https://mp.weixin.qq.com/s/v2sRMQY7F7lGtNjU0RWAMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人人学懂免疫学：第十期</title>
    <updated>2020-11-05T20:33:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/IucpxFSCFSWRE6HIiUC27Q</id>
    <link href="https://mp.weixin.qq.com/s/IucpxFSCFSWRE6HIiUC27Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药事纵横投稿须知：稿费又上调，欢迎投稿</title>
    <updated>2020-11-05T20:33:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/ngkt65oNj38Pqg2AVPoQbw</id>
    <link href="https://mp.weixin.qq.com/s/ngkt65oNj38Pqg2AVPoQbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国际化是大势所趋：今年我国药企已获82个ANDA批文</title>
    <updated>2020-11-04T17:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/pCqDV3v2mcO6NKuFaaoqEw</id>
    <link href="https://mp.weixin.qq.com/s/pCqDV3v2mcO6NKuFaaoqEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【火热报名中】CCIT 2020携行业专家聚焦密封性研究，名额即满，报名从速</title>
    <updated>2020-11-04T17:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/DScFZmO9imHX24C5sb34XA</id>
    <link href="https://mp.weixin.qq.com/s/DScFZmO9imHX24C5sb34XA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这些注射剂总销售额过千亿，离集采还有多远</title>
    <updated>2020-11-04T17:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/6OqguqR8gVHnnfSutzCqdw</id>
    <link href="https://mp.weixin.qq.com/s/6OqguqR8gVHnnfSutzCqdw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>水合物、溶剂化物和无定形物的固态表征</title>
    <updated>2020-11-04T17:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/_-FZG1ysgu-UitrYl0xXEQ</id>
    <link href="https://mp.weixin.qq.com/s/_-FZG1ysgu-UitrYl0xXEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>特药险，为重特大疾病医疗保险和救助机制提供何种借鉴</title>
    <updated>2020-11-03T22:02:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/JF8Bfoy3-XCt9lecE8omLg</id>
    <link href="https://mp.weixin.qq.com/s/JF8Bfoy3-XCt9lecE8omLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>案例说：制药企业的转型路径</title>
    <updated>2020-11-03T22:02:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/ct_Mb5h_7uQrPfn30gQTng</id>
    <link href="https://mp.weixin.qq.com/s/ct_Mb5h_7uQrPfn30gQTng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药研究中稳定性指示的分析方法开发与验证概要</title>
    <updated>2020-11-03T22:02:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/0G1kJIjeZahIAD8I_ajVkA</id>
    <link href="https://mp.weixin.qq.com/s/0G1kJIjeZahIAD8I_ajVkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10大MNC药企Q3财报出炉：赛诺菲、辉瑞、诺华、罗氏、礼来、GSK……</title>
    <updated>2020-11-02T14:35:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/QcYISWn0LXkTN7Qf40zpPQ</id>
    <link href="https://mp.weixin.qq.com/s/QcYISWn0LXkTN7Qf40zpPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>